Izzo, I., Albini, L., Calabresi, A., Motta, D., Bellagamba, R., Fezza, R., . . . Torti, C. (2010). A magnifying glass onto renal function and serum lipid evolutions after tenofovir (TDF) and emtricitabine (FTC) in combination with atazanavir/ritonavir (ATV/r) versus efavirenz (EFV) as first-line HAART (the INCA trial). The International AIDS Society.
Chicago-стиль цитированияIzzo, I., et al. A Magnifying Glass Onto Renal Function and Serum Lipid Evolutions After Tenofovir (TDF) and Emtricitabine (FTC) in Combination With Atazanavir/ritonavir (ATV/r) Versus Efavirenz (EFV) As First-line HAART (the INCA Trial). The International AIDS Society, 2010.
MLA-цитированиеIzzo, I., et al. A Magnifying Glass Onto Renal Function and Serum Lipid Evolutions After Tenofovir (TDF) and Emtricitabine (FTC) in Combination With Atazanavir/ritonavir (ATV/r) Versus Efavirenz (EFV) As First-line HAART (the INCA Trial). The International AIDS Society, 2010.